Stock Details
FRE.DE is Fresenius SE & Co. KGaA's stock. Stock exchange XETRA (Currency EUR). Average price in 50 days is 25.10โ‚ฌ. Average daily volumn in 3 months 1.49M. Market cap 12.31B



Stock symbol : FRE.DE. Exchange : XETRA. Currency : EUR
Lastest price : 21.85โ‚ฌ. Total volume : 2.38M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Fresenius SE & Co. KGaA (FRE.DE)
Last Price
21.85โ‚ฌ
Change
-0.70
Volume
2.38M

Previous Close22.55
Open22.77
Day Range21.84-22.77
Bid21.87 x N/A
Ask21.88 x N/A
Volume2.38M
Average Volume1.49M
Market Cap12.31B
Beta1.11
52 Week Range21.84-42.50
Trailing P/E7.16
Foward P/E6.04
Dividend (Yield %)3.94%
Ex-Dividend Date2022-05-16



Financial Details


According to Fresenius SE & Co. KGaA's financial reports the company's revenue in 2021 were 37.52B an increase( +2.78%) over the years 2020 revenue that were of 36.28B. In 2021 the company's total earnings were 1.82B while total earnings in 2020 were 1.71B(0%).


Loading ...



Organization

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi s... egment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hรถhe, Germany.

Market Cap:
12.31B
Revenue:
37.52B
Total Assets:
71.96B
Total Cash:
2.76B


News about "Fresenius SE & Co. KGaA"

Fresenius SE & Co KGaA

Source from : Reuters - 2 days ago

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for ...See details»


fresenius-se-co-kgaa-otcmktsfsnuy-receives-average-recommendation-of-hold-from-analysts-image

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Receives Average Recommendation of โ€œHoldโ€ from Analysts

Source from : Defense World - 7 days ago

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY โ€“ Get Rating) has received an average recommendation of โ€œHoldโ€ from the nine research firms that are presently covering the company, Marketbeat reports. Four ...See details»


fresenius-medical-care-ag-co-kgaa-nysefms-receives-new-coverage-from-analysts-at-stocknewscom-image

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives New Coverage from Analysts at StockNews.com

Source from : Defense World - 16 hours ago

StockNews.com started coverage on shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS โ€“ Get Rating) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the ...See details»


DGAP-DD: Fresenius SE & Co. KGaA english

Source from : Business Insider - 26 days ago

Archive at www.dgap.de 77689 29.08.2022 CET/CEST SHARE THIS POST Fresenius NewsMORE Related Stocks Find News News Indices Commodities Currencies Stocks ...See details»


Fresenius Medical Care AG & Co. KGaA ADR

Source from : Wall Street Journal - 11 days ago

Fresenius Medical Care AG & Co. KGaA, Fresenius Management SE, Else Krรถner-Fresenius-Stiftung Dorothea Wenzel Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, H. Lundbeck A/S ...See details»


Fresenius SE

Source from : Barron's - 28 days ago

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following ...See details»


fresenius-kabi-receives-us-fda-approval-for-biosimilar-stimufend-pegfilgrastim-fpgk-image

Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufendยฎ (pegfilgrastim - fpgk)

Source from : The Bakersfield Californian - 18 days ago

Fresenius Kabi, a global health care company that specializes in pharmaceuticals, medical technologies, and nutrition products for critical and chronic conditions, announced today that the United ...See details»


germany-fresenius-taps-bond-markets-for-750m-over-five-years-image

Germany: Fresenius taps bond markets for โ‚ฌ750m over five years

Source from : laingbuissonnews - 11 days ago

Fresenius Medical Care, a leading global provider of products and services for renal diseases, has placed โ‚ฌ750m of five-year bonds. The bonds pay an annual coupon of 3.875% and were priced at 99.635% ...See details»


Fresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE Award

Source from : Yahoo Finance - 12 days ago

Sept. 12, 2022 /PRNewswire/ -- Fresenius Kidney Care, the nation's leading provider of kidney care services, is pleased to announce its new annual recognition program to honor frontline nephrology ...See details»


Fresenius Kabi Selected to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange

Source from : WSIL-TV - 11 days ago

Fresenius Kabi has been selected to exhibit the Ivenix Infusion System at the Vizient Innovative Technology Exchange. Vizient, Inc, the nationโ€™s largest member-driven health care performance ...See details»


Pain Management Market Size Will Achieve USD 83,348 Million by 2030 growing at 6.5% CAGR - Exclusive Report by Acumen Research and Consulting

Source from : Benzinga.com - 25 days ago

The Global Pain Management Market is anticipated to grow at a CAGR of around 6.5% during the forecast period 2022 to 2030 ...See details»


fresenius-kabi-samsung-bioepis-lock-horns-again-over-humira-biosimilar-image

Fresenius Kabi, Samsung Bioepis lock horns again over Humira biosimilar

Source from : lawyerly - 10 days ago

Please login to bookmark Username or Email Address Password Remember Me German biotech Fresenius Kabi has struck back at Samsung Bioepisโ€™s latest attack on [โ€ฆ]See details»


Heparin Market Share, Size, Industry Demand, Growth Rate, SWOT Analysis, and Business Development by 2028

Source from : MarketWatch - 12 days ago

The global โ€œHeparin Market Size" is expected to rise with an impressive CAGR and generate the highest revenue by ...See details»


Physiological Saline Market To See Strong Growth Momentum | Baxter, Fresenius Kabi, Hospira

Source from : MENAFN - 11 days ago

Physiological Saline Market PORTLAND, OREGON, UNITED STATES, September 13, 2022 /EINPresswire.com / -- Allied Market Research Analyst hav ...See details»